TY  - JOUR
T1  - central venous catheter related vena cava superior syndrome after renal transplantation in two case
AU  - Çam, Ender
AU  - Ülger, Fatma
PY  - 2022
DA  - March
Y2  - 2021
JF  - Deneysel ve Klinik Tıp Dergisi
JO  - J. Exp. Clin. Med.
PB  - Ondokuz Mayıs University
WT  - DergiPark
SN  - 1309-4483
SP  - 557
EP  - 559
VL  - 39
IS  - 2
LA  - en
AB  - Vena cava superior syndrome is a specific clinical disease; very important obstruction of the large central veins. Catheter-related deep vein thrombosis(DVT) and vena cava superior (VCS) syndrome are rare but serious complications that require specific care in these selected renal transplant recipient.Thrombosis formation, is a major complication of CVC attempts, however, arterial puncture, hematoma, and pneumothorax are more common complications. Mechanical complications of central venous catheter (CVC) have been reported in 5% to 19%. Incidences of CVC thrombosis have been reported in up to 66% of patients in venographic studies, however; vena cava superior (VCS) syndrome is a rare complication. After evaluating the catheter-related thrombosis risk, hemodialysis catheters were found to be the highest risk in comparison with other catheters. Catheter-related deep vein thrombosis (DVT) and VCS syndrome are rare but serious complications require specific care in these renal transplant recipients. We report two cases of vena cava superior syndrome due to CVC thrombosis after kidney transplantation in two chronic renal disease patients with histories of previous catheter thrombosis.
KW  - end stage renal disease
KW  - vena cava superior syndrome
KW  - central catheter
CR  - REFERENCES:
1.	McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348(12):1123-1133.
CR  - 2.	Kamphuisen PW, Lee AY. Catheter-related thrombosis: lifeline or a pain in the neck? Hematology Am Soc Hematol Educ Program. 2012:638-644.
CR  - 3.	Wigmore TJ, Smythe JF, Hacking MB, Raobaikady R, MacCallum NS. Effect of the implementation of NICE guidelines for ultrasound guidance on the complication rates associated with central venous catheter placement in patients presenting for routine surgery in a tertiary referral centre. Br J Anaesth. 2007;99(5):662-665.
CR  - 4.	Malinoski D, Ewing T, Bhakta A, et al. Which central venous catheters have the highest rate of catheter associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit. J Trauma Acute Care Surg. 2013;74(2):454-460; discussion 461-452.
CR  - 5.	Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thrombo embolism. J Am Soc Nephrol. 2008;19(1):135-140.
CR  - 6.	Lee JM, Kim ES, Park CS, SH. K. Changes in thromboelastographic findings after renal transplantation in patients with chronic renal failure. Korean J Anesthesiol. 2004;47(1):75-81.
CR  - 7.	Irish A. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention. Am J Cardiovasc Drugs. 2004;4(3):139-149.
CR  - 8.	Friedman GS, Meier-Kriesche HU, Kaplan B, et al. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation. 2001;72(6):1073-1078.
CR  - 9.	Osman Y, Shokeir A, Ali-el-Dein B, et al. Vascular complications after live donor renal transplantation: study of risk factors and effects on graft and patient survival. J Urol. 2003;169(3):859-862.
CR  - 10.	Lundin C, Bersztel A, Wahlberg J, Wadstrom J. Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation. Ups J Med Sci. 2002;107(1):9-15.
CR  - 11.	Mohan P, Murphy DM, Counihan A, Cunningham P, Hickey DP. The role of intraoperative heparin in cyclosporine treated cadaveric renal transplant recipients. J Urol. 1999;162(3 Pt 1):682-684.
CR  - 12.	Shullo MA, Rose ML, Vivas C, et al. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy. 2002;22(2):184-187.
CR  - 13.	Kaneko J, Sugawara Y, Tamura S, et al. Coagulation and fibrinolytic profiles and appropriate use of heparin after living-donor liver transplantation. Clin Transplant. 2005;19(6):804-809.
CR  - 14.	Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am.  2009;27(2):243-255.
UR  - https://dergipark.org.tr/en/pub/omujecm/issue//984340
L1  - https://dergipark.org.tr/en/download/article-file/1931388
ER  -